No abstract available
Keywords:
Conjunctiva; Eye; Immune checkpoint inhibitors; Immunotherapy; Orbital extension; PD-1/PD-L1 inhibitors; Squamous cell carcinoma.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Carcinoma, Squamous Cell / diagnostic imaging
-
Carcinoma, Squamous Cell / secondary
-
Carcinoma, Squamous Cell / therapy*
-
Conjunctival Neoplasms / diagnostic imaging
-
Conjunctival Neoplasms / pathology
-
Conjunctival Neoplasms / therapy*
-
Female
-
Humans
-
Immunotherapy*
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Orbital Neoplasms / diagnostic imaging
-
Orbital Neoplasms / secondary
-
Orbital Neoplasms / therapy*
-
Tomography, X-Ray Computed
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
cemiplimab
-
pembrolizumab